Incensus Pharma IvS: Financial statements 2019
CVR: 37162949
Source: annual report 2019, Danish Business Authority
01/01/2019 – 31/12/2019
Incensus Pharma IvS (CVR 37162949) has filed annual accounts for 2019. In 2019, the company reported a gross profit of DKK -1,484 and a net result of DKK -1,625 compared with DKK -1,352 the year before. Equity in the 2019 report amounted to DKK -5,744.
- Gross Profit
- DKK -1,484
- Profit/Loss
- DKK -1,625
- Equity
- DKK -5,744
- Total Assets
- DKK 4
Development
| Year | Revenue | Gross Profit | Profit/Loss | Equity | Employees |
|---|---|---|---|---|---|
| 2019 | - | -1 t. | -2 t. | -6 t. | - |
| 2018 | - | -1 t. | -1 t. | -4 t. | - |
| 2017 | - | -1 t. | -1 t. | -3 t. | - |
Official annual report
Screen every Danish company
Combine filters on financials, industry, geography, property and risk, and instantly see which companies match.
Try company screeningEvents in 2019
Incensus Pharma IvS has published its annual report for 2018. Gross profit came to DKK -1,250, and the net result was DKK -1,352.
About Incensus Pharma IvS
Incensus Pharma IvS was a Danish company of the type Iværksætterselskab based in Hinnerup, founded in 2015. The company has been dissolved on 25 May 2021. The company was registered under the industry Forskning og eksperimentel udvikling indenfor bioteknologi. In 2020, the company reported a gross profit of DKK -1,500 and a net result of DKK -1,500 compared with DKK -1,625 the year before. Equity in the 2020 report amounted to DKK -7,244.